- Vaxxinity Issues Shareholder Letter
- Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
- Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
- Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
- Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
- Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
- Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
- Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
- Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
More ▼
Key statistics
On Friday, Vaxxinity Inc (VAXX:PKL) closed at 0.0949, 109.49% above the 52 week low of 0.0453 set on May 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.10 |
---|---|
High | 0.10 |
Low | 0.0803 |
Bid | -- |
Offer | -- |
Previous close | 0.10 |
Average volume | 313.08k |
---|---|
Shares outstanding | 126.78m |
Free float | 55.66m |
P/E (TTM) | -- |
Market cap | 12.03m USD |
EPS (TTM) | -0.4499 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 20:58 BST.
More ▼